ARKG基因组革命投资追踪
数据来源：官网 ARKG 是凯瑟琳伍德管理的交易所交易基金（ETF），主要投资于基因组学领域的股票。“ARK基因革命基金交易分享大师号”基于ARKG的每日披露调仓报告，帮助投资者追踪其投资策略。
IP属地：未知
0关注
1646粉丝
0主题
0勋章
ARKG Investment Tracker position change: Decreased position in Veracyte by 6,910 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 3.38% of the total position.
ARKG Investment Tracker position change: Increased position in ATAI Life Sciences B.V.* by 56,930 shares, the number of shares held increased 3% compared to the previous period and now represents 0.85% of the total position.
ARKG Investment Tracker position change: Decreased position in CRISPR Therapeutics AG by 10,645 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 9.87% of the total position.
ARKG Investment Tracker position change: Decreased position in Regeneron Pharmaceuticals by 70 shares, the number of shares held decreased 0.6% compared to the previous period and now represents 0.64% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 155 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 0.88% of the total position.
ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 9,115 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 1.2% of the total position.
ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 16,705 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 3.96% of the total position.
ARKG Investment Tracker position change: Decreased position in Exact Sciences by 1,485 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 1.17% of the total position.
ARKG Investment Tracker position change: Decreased position in Illumina by 2,165 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 3.29% of the total position.
ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 390 shares, the number of shares held decreased 0.61% compared to the previous period and now represents 0.76% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 1,690 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 4.49% of the total position.
ARKG Investment Tracker position change: Decreased position in Guardant Health Inc. by 4,845 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 4.19% of the total position.
ARKG Investment Tracker position change: Decreased position in Amgen by 285 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 1.16% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 18,620 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 3.64% of the total position.
ARKG Investment Tracker position change: Decreased position in Beam Therapeutics, Inc. by 11,740 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 4.34% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 67,920 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 4.93% of the total position.
ARKG Investment Tracker position change: Decreased position in Adaptive Biotechnologies Corp by 19,240 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 3.9% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 64,800 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 1.22% of the total position.
ARKG Investment Tracker position change: Decreased position in Veeva by 240 shares, the number of shares held decreased 0.61% compared to the previous period and now represents 1.01% of the total position.
ARKG Investment Tracker position change: Decreased position in Incyte by 890 shares, the number of shares held decreased 0.62% compared to the previous period and now represents 1.13% of the total position.
去老虎APP查看更多动态